| 1 |
Dalamaga M, Nasiri-ansari N, Spyrou N. Perspectives and Challenges of COVID-19 with Obesity-Related Cancers. Cancers 2023;15:1771. [DOI: 10.3390/cancers15061771] [Reference Citation Analysis]
|
| 2 |
Carson MD, Warner AJ, Geiser VL, Hathaway-Schrader JD, Alekseyenko AV, Marshall J, Westwater C, Novince CM. Prolonged Antibiotic Exposure during Adolescence Dysregulates Liver Metabolism and Promotes Adiposity in Mice. Am J Pathol 2023:S0002-9440(23)00083-4. [PMID: 36906264 DOI: 10.1016/j.ajpath.2023.02.014] [Reference Citation Analysis]
|
| 3 |
Liu H, Yan C, Hao C, Wang D, Liu Y, Luo ZB, Han SZ, Wang JX, Li D, Zhu J, Chang SY, Yang LH, Lin X, Yan C, Kang JD, Quan LH. Dynamic changes in intestinal microbiota and metabolite composition of pre-weaned beef calves. Microb Pathog 2023;175:105991. [PMID: 36649780 DOI: 10.1016/j.micpath.2023.105991] [Reference Citation Analysis]
|
| 4 |
Avgerinos KI, Liu J, Dalamaga M. Could exercise hormone irisin be a therapeutic agent against Parkinson's and other neurodegenerative diseases? Metabol Open 2023;17:100233. [PMID: 36785617 DOI: 10.1016/j.metop.2023.100233] [Reference Citation Analysis]
|
| 5 |
Yi R, Liu T, Xue R, Yang Z. Effect of Lactobacillus isolated from Chinese fermented food on antibiotic induced intestinal microflora disorder in early life of mice. Food Sci Technol 2023;43. [DOI: 10.1590/fst.121422] [Reference Citation Analysis]
|
| 6 |
Luo S, Zhang H, Jiang X, Xia Y, Tang S, Duan X, Sun W, Gao M, Chen C, Zou Z, Zhou L, Qiu J. Antibiotics administration alleviates the high fat diet-induced obesity through altering the lipid metabolism in young mice. Lipids 2023;58:19-32. [PMID: 36253942 DOI: 10.1002/lipd.12361] [Reference Citation Analysis]
|
| 7 |
Karampela I. Perspectives in vaccines, immune response, therapeutic interventions and COVID-19. Metabol Open 2023;17:100223. [PMID: 36570684 DOI: 10.1016/j.metop.2022.100223] [Reference Citation Analysis]
|
| 8 |
Lempesis IG, Liu J, Dalamaga M. The catcher in the gut: Tirzepatide, a dual incretin analog for the treatment of type 2 diabetes mellitus and obesity. Metabolism Open 2022;16:100220. [DOI: 10.1016/j.metop.2022.100220] [Reference Citation Analysis]
|
| 9 |
Lebeaux RM, Madan JC, Nguyen QP, Coker MO, Dade EF, Moroishi Y, Palys TJ, Ross BD, Pettigrew MM, Morrison HG, Karagas MR, Hoen AG. Impact of antibiotics on off-target infant gut microbiota and resistance genes in cohort studies. Pediatr Res 2022;92:1757-66. [PMID: 35568730 DOI: 10.1038/s41390-022-02104-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 10 |
Zhong S, Wu X, Zhang D, Du S, Shen J, Xiao L, Zhu Y, Xu Y, Lin Y, Yin L, Rao M, Lu S. Antibiotics in urine from general adults in Shenzhen, China: Demographic-related difference in exposure levels. Science of The Total Environment 2022;843:157070. [DOI: 10.1016/j.scitotenv.2022.157070] [Reference Citation Analysis]
|
| 11 |
Ternák G, Németh M, Rozanovic M, Márovics G, Bogár L. “Growth-Promoting Effect” of Antibiotic Use Could Explain the Global Obesity Pandemic: A European Survey. Antibiotics 2022;11:1321. [DOI: 10.3390/antibiotics11101321] [Reference Citation Analysis]
|
| 12 |
Bays HE, Golden A, Tondt J. Thirty Obesity Myths, Misunderstandings, and/or Oversimplifications: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obesity Pillars 2022;3:100034. [DOI: 10.1016/j.obpill.2022.100034] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Mo J, Ni J, Zhang M, Xu Y, Li Y, Karim N, Chen W. Mulberry Anthocyanins Ameliorate DSS-Induced Ulcerative Colitis by Improving Intestinal Barrier Function and Modulating Gut Microbiota. Antioxidants 2022;11:1674. [DOI: 10.3390/antiox11091674] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Kong L, Yu S, Gu L, Geng M, Zhang D, Cao H, Liu A, Wang Q, Wang S, Tao F, Liu K. Associations of typical antibiotic residues with elderly blood lipids and dyslipidemia in West Anhui, China. Ecotoxicol Environ Saf 2022;242:113889. [PMID: 35853362 DOI: 10.1016/j.ecoenv.2022.113889] [Reference Citation Analysis]
|
| 15 |
Yoon JB, Hwang S, Yang JH, Lee S, Bang WY, Moon KH. Dynamics of the Gut Microbiome and Transcriptome in Korea Native Ricefish (Oryzias latipes) during Chronic Antibiotic Exposure. Genes 2022;13:1243. [DOI: 10.3390/genes13071243] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Gough EK. The impact of mass drug administration of antibiotics on the gut microbiota of target populations. Infect Dis Poverty 2022;11:76. [PMID: 35773678 DOI: 10.1186/s40249-022-00999-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Parodi G, Leite G, Pimentel ML, Barlow GM, Fiorentino A, Morales W, Pimentel M, Weitsman S, Mathur R. The Response of the Rodent Gut Microbiome to Broad-Spectrum Antibiotics Is Different in Males and Females. Front Microbiol 2022;13:897283. [PMID: 35756061 DOI: 10.3389/fmicb.2022.897283] [Reference Citation Analysis]
|
| 18 |
Shapiro D, Kapourchali FR, Santilli A, Han Y, Cresci GAM. Targeting the Gut Microbiota and Host Immunity with a Bacilli-Species Probiotic during Antibiotic Exposure in Mice. Microorganisms 2022;10:1178. [PMID: 35744696 DOI: 10.3390/microorganisms10061178] [Reference Citation Analysis]
|
| 19 |
Shetye B, Hamilton FR, Bays HE. Bariatric surgery, gastrointestinal hormones, and the microbiome: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obesity Pillars 2022;2:100015. [DOI: 10.1016/j.obpill.2022.100015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 20 |
Fotis D, Liu J, Dalamaga M. Could gut mycobiome play a role in NAFLD pathogenesis? Insights and therapeutic perspectives. Metabolism Open 2022;14:100178. [DOI: 10.1016/j.metop.2022.100178] [Reference Citation Analysis]
|
| 21 |
Yan J, Nie Y, Liu Y, Li J, Wu L, Chen Z, He B. Yiqi-Bushen-Tiaozhi Recipe Attenuated High-Fat and High-Fructose Diet Induced Nonalcoholic Steatohepatitis in Mice via Gut Microbiota. Front Cell Infect Microbiol 2022;12:824597. [DOI: 10.3389/fcimb.2022.824597] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 22 |
Dalamaga M, Zheng L, Liu J. Gut mycobiome as a promising preventive and therapeutic target for metabolic disorders. Metabolism Open 2022;13:100168. [DOI: 10.1016/j.metop.2022.100168] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 23 |
Tsigalou C, Konstantinidis T, Aloizou A, Bezirtzoglou E, Tsakris A. Future Therapeutic Prospects in Dealing with Autoimmune Diseases: Treatment Based on the Microbiome Model. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases 2022. [DOI: 10.1007/978-981-19-4800-8_25] [Reference Citation Analysis]
|
| 24 |
Vallianou N, Christodoulatos GS, Karampela I, Tsilingiris D, Magkos F, Stratigou T, Kounatidis D, Dalamaga M. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives. Biomolecules 2022;12:56. [DOI: 10.3390/biom12010056] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 25 |
Zeinali LI, Giuliano S, Lakshminrusimha S, Underwood MA. Intestinal Dysbiosis in the Infant and the Future of Lacto-Engineering to Shape the Developing Intestinal Microbiome. Clin Ther 2021:S0149-2918(21)00459-8. [PMID: 34922744 DOI: 10.1016/j.clinthera.2021.11.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
Lebeaux RM, Madan JC, Nguyen QP, Coker MO, Dade EF, Moroishi Y, Palys TJ, Ross BD, Pettigrew MM, Morrison HG, Karagas MR, Hoen AG. Impact of antibiotics to off-target infant gut microbiota and resistance genes in cohort studies.. [DOI: 10.1101/2021.11.02.21265394] [Reference Citation Analysis]
|
| 27 |
Hotinger JA, Morris ST, May AE. The Case against Antibiotics and for Anti-Virulence Therapeutics. Microorganisms 2021;9. [PMID: 34683370 DOI: 10.3390/microorganisms9102049] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 28 |
Kitani-Morii F, Friedland RP, Yoshida H, Mizuno T. Drosophila as a Model for Microbiota Studies of Neurodegeneration. J Alzheimers Dis 2021;84:479-90. [PMID: 34569965 DOI: 10.3233/JAD-215031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 29 |
Narayanan N, Lin T, Vinarov D, Bucek T, Johnson L, Mathew C, Chaudhry S, Brunetti L. Relationship Between Multidrug-Resistant Enterobacterales and Obesity in Older Adults. Infect Drug Resist 2021;14:2527-32. [PMID: 34234480 DOI: 10.2147/IDR.S317014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 30 |
Vallianou N, Kounatidis D, Christodoulatos GS, Panagopoulos F, Karampela I, Dalamaga M. Mycobiome and Cancer: What Is the Evidence? Cancers (Basel) 2021;13:3149. [PMID: 34202433 DOI: 10.3390/cancers13133149] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
|
